Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A double blinded, placebo-controlled, two-way parallel clinical trial to confirm the safety and efficacy of Pennsaid in the treatment of the osteoarthritic knee
ISRCTN ISRCTN53366886
ClinicalTrials.gov identifier
Public title A double blinded, placebo-controlled, two-way parallel clinical trial to confirm the safety and efficacy of Pennsaid in the treatment of the osteoarthritic knee
Scientific title
Acronym N/A
Serial number at source RA-CP-109
Study hypothesis To evaluate the efficacy and safety of a topical diclofenac solution compared with a vehicle control solution in the treatment of the symptoms of osteoarthritis of the knee.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Canada
Disease/condition/study domain Osteoarthritis of the knee
Participants - inclusion criteria 1. Primary osteoarthritis of the knee characterised by deterioration and abrasion of articular cartilage and/or formation of new bone at the joint surface
2. Age between 40 and 85 years
3. Moderate flare of pain after discontinuation of prior non-steroidal anti-inflammatory drug (NSAID)/analgesic
4. Non-pregnant
Participants - exclusion criteria 1. Sensitivity to NSAIDs
2. Severe, uncontrolled systemic disease
3. Gastro-duodenal ulcer
4. Secondary osteoarthritis
5. Corticosteroid use
6. Prior intra-articular viscosupplementation
7. Fibromyalgia
Anticipated start date 01/11/1999
Anticipated end date 31/08/2000
Status of trial Completed
Patient information material
Target number of participants 200
Interventions Topical diclofenac solution versus vehicle control solution.
Primary outcome measure(s) Change from baseline to final assessment in pain and physical function, assessed using the Western Ontario McMaster Universities Osteoarthritis (WOMAC) subscales, and patient global assessment
Secondary outcome measure(s) Change from baseline to final assessment in stiffness, assessed using the WOMAC subscale
Sources of funding Dimethaid Research Inc. (Canada)
Trial website
Publications Results in http://www.ncbi.nlm.nih.gov/pubmed/16086839
Contact name Dr  Philip  Baer
  Address Malvern Medical Centre
1333 Neilson Road
  City/town Toronto, Ontario
  Zip/Postcode M1B 4Y9
  Country Canada
Sponsor Dimethaid Research Inc. (Canada)
  Address 1405 Denison Street
  City/town Markham, Ontario
  Zip/Postcode L3R 5V2
  Country Canada
  Sponsor website: http://www.dimethaid.com/
Date applied 25/07/2005
Last edited 11/04/2008
Date ISRCTN assigned 26/07/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central